John Schroyer
After three months of recreational marijuana sales in Connecticut, the medical side of the industry is still outperforming adult use on sales, with $12.6 million in MMJ sales and $9.6 million in recreational for the month of March.
That’s after medical cannabis sold $8 million in January compared to $5.1 million for recreational, and in February, those numbers both spiked to $11.4 million in medical sales and $7 million in recreational sales, according to a press release from the Connecticut Department of Consumer Protection.
The number of cannabis products sold has also trended steadily upwards since the beginning of the year, for both medical and recreational categories, the state’s data showed. In January, there were just 114,000 recreational marijuana products sold, which went up to 168,000 in February and then 234,000 in March. Medical marijuana product sales were 227,000 in January, then 316,000 in February, and 339,000 in March.
For 2023, the state has sold a grand total of $53.7 million in cannabis as of March 31, according to state data.
For the same time frame, prices for recreational cannabis trended downward, while medical marijuana prices have stayed about flat, the state reported.
In January, the average recreational cannabis product cost $44.61, which dropped in February to $41.82, and then to $40.69 in March. For medical marijuana products, the average in January was $35.68, which increased slightly to $36.11 in February, and then up again in March to $37.06.
Wholesale prices have also come down since the recreational market launched in January, one dispensary owner told CT Insider. And, he said, the primary reason medical prices have notched up slightly is that concentrates have become more readily available again in that same time frame, which affected customer basket prices.
